Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,063.56 -21.63 (-1.99%)

Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

99 100 Next >

Viking Global Dumps UnitedHealth, Loads Up On Disney, McDonald's, JPMorgan, AMD In Q2 Shake-Up ↗

August 15, 2025

Via Benzinga

Guidance Watch: 2 Companies Bullishly Raising Forecasts ↗

August 15, 2025

Several companies, including Palantir and Eli Lilly, have raised guidance, reflecting positivity surrounding their results. Let’s take a closer look at what drove the strong quarters.

Via Talk Markets

Eli Lilly Strikes $1.3 Billion Deal With Superluminal To Develop AI-Driven Obesity Drugs ↗

August 15, 2025

Eli Lilly and Co (NYSE: LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs through artificial intelligence (AI) to treat obesity and other...

Via Benzinga

Topics Artificial Intelligence

1 Healthcare Stock for Long-Term Investors and 2 We Ignore

August 15, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

Eli Lilly Inks Up To $1.3B Deal With Superluminal Medicines To Develop Obesity Drugs ↗

August 14, 2025

Via Stocktwits

Stay informed with the top movers within the S&P500 index on Thursday. ↗

August 14, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.

Via Chartmill

This Chinese EV-Maker Gets A Price Target Hike From JPMorgan, But Retail’s Concerned About The Stock’s Performance ↗

August 14, 2025

JPMorgan lifted fiscal 2026 and 2027 volume estimates for Nio by 11% to 13% on stronger volume from the company's new L90 and L80 SUV launches.

Via Stocktwits

Eli Lilly To Hike Mounjaro Prices By A Whopping 170% In UK: Retail Expects Stock To See Smooth Rally Till $720 ↗

August 14, 2025

According to the Financial Times, the price for a month’s supply of the highest doses of the drug will rise from £122 to £330, an increase of 170%.

Via Stocktwits

Topics Government World Trade

Eli Lilly Hikes UK Mounjaro Price By Up To 170% As Trump Pressure Mounts ↗

August 14, 2025

President Donald Trump is moving ahead with his Most Favored Nation pricing plan and Eli Lilly is playing ball.

Via Investor's Business Daily

Topics Government

These S&P500 stocks are moving in today's session ↗

August 14, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Eli Lilly & Co.: Deep Pullback Near 52‑Week Low Tests Strong Fundamentals And Bullish Analyst Targets ↗

August 14, 2025

LLY has given back meaningful ground over recent horizons: the stock is down approximately $103.94 (≈-13.6%) month-to-date and about $119.68 (≈-15.4%) year-to-date.

Via Talk Markets

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India ↗

August 14, 2025

Eli Lilly will raise Mounjaro's UK price by 170% in September while launching its Kwikpen injector in India, intensifying competition with Novo Nordisk in the global obesity drug market.

Via Benzinga

5 Must-Read Analyst Questions From Eli Lilly’s Q2 Earnings Call

August 14, 2025

Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit expectations, yet the market response was notably negative. Management attributed...

Via StockStory

Topics Earnings

3 Market-Beating Stocks to Keep an Eye On

August 14, 2025

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the...

Via StockStory

Why Eli Lilly Stock Popped Today ↗

August 13, 2025

The GLP-1 weight loss wars have gone global.

Via The Motley Fool

Eli Lilly (LLY) Stock Trades Up, Here Is Why

August 13, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the afternoon session after reports of significant insider buying by top executives, including the CEO, sent the stock...

Via StockStory

Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens ↗

August 13, 2025

Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.

Via Benzinga

Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst ↗

August 13, 2025

William Blair projects strong VENTURE-Oral trial results for Viking's VK2735, citing flexibility and market opportunity after a rival's setback.

Via Benzinga

How Novo Nordisk's Weight-Loss Drug Could Unlock A Better Future For Biogen's Alzheimer's Treatment ↗

August 13, 2025

Biogen CEO Chris Viehbacher says Novo Nordisk's Alzheimer's trial success could lead to combination therapies, boosting treatment options despite competition from Eli Lilly.

Via Benzinga

Nvidia To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

August 13, 2025

Via Benzinga

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound ↗

August 13, 2025

Texas Attorney General Ken Paxton has sued Eli Lilly, alleging the drugmaker offered illegal incentives to providers, leading to millions in improper Medicaid claims.

Via Benzinga

Topics Law Enforcement Lawsuit

The 3 Things That Matter for Viking Therapeutics Now ↗

August 13, 2025

Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

Via The Motley Fool

Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years ↗

August 12, 2025

Via Benzinga

Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance ↗

August 12, 2025

Texas Attorney General Ken Paxton alleged that Lilly offered illegal incentives to medical providers in Texas designed to steer providers toward prescribing Lilly’s drugs.

Via Stocktwits

Topics Fraud Law Enforcement Lawsuit

Top 5% Biotech, Insmed, Hits A Record High On Its 'Skeleton Key' Approval ↗

August 12, 2025

Insmed stock hit a record high Tuesday after the FDA approved its drug, brensocatib, for patients with a lung condition.

Via Investor's Business Daily

Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now ↗

August 12, 2025

Novo Nordisk filed more Wegovy lawsuits against smaller U.S. firms, as the FDA sets a compounding deadline. Hims & Hers was not named in the new cases.

Via Benzinga

Topics Lawsuit

UK Government, Eli Lilly Partner To Target Obesity Health Gaps ↗

August 12, 2025

A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and pharmacy-based services by summer 2026.

Via Benzinga

Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock ↗

August 12, 2025

Investors have a tough choice between these two excellent companies.

Via The Motley Fool

If You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today ↗

August 12, 2025

The biopharmaceutical company has an exciting lead compound in development.

Via The Motley Fool

1 Reason to Buy Eli Lilly (LLY) Stock ↗

August 12, 2025

There's a reason you might want to hold off on buying Lilly stock.

Via The Motley Fool

Topics Government World Trade

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.